The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients

Gane, Edward J. ; Weilert, Frank ; Orr, David W. ; Keogh, Geraldine F. ; Gibson, Michael ; Lockhart, Michelle M. ; Frampton, Christopher M. ; Taylor, Kenneth M. ; Smith, Robin A. J. ; Murphy, Michael P.

Liver international, 2010-08, Vol.30 (7), p.1019-1026 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível